Lot-to-Lot Variability in Biologics and Biosimilars: What Patients and Providers Need to Know
Lot-to-lot variability is normal in biologics and biosimilars due to their complex manufacturing. Unlike generics, these drugs aren't identical across batches - but they're rigorously controlled to ensure safety and effectiveness.